Why Choose Microdose for Peace?
Personalized consultations tailored to your needs. Experience the benefits of safe and effective microdosing.
Curious about Low, Medium, and Macro (Clinical) Doses?
References
- Beug, M. W., & Bigwood, J. (1982). Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, USA. Journal of Ethnopharmacology, 5(3), 271-285.
https://www.researchgate.net/publication/15998152_Psilocybin_and_psilocin_levels_in_twenty_species_from_seven_genera_of_wild_mushrooms_in_the_Pacific_Northwest_USA - Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268-283.
https://pubmed.ncbi.nlm.nih.gov/16826400/ - Hutcheson, B. S., Lucas, C. J., & Luckett, T. (2022). Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Translational Psychiatry, 12(1), 1-9.
https://www.nature.com/articles/s41398-022-01821-5 - Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology, 22(6), 603-620.
https://pubmed.ncbi.nlm.nih.gov/18593734/ - Passie, T., Seifert, J., Schneider, U., & Emrich, H. M. (2002). The pharmacology of psilocybin. Addiction Biology, 7(4), 357-364.
https://pubmed.ncbi.nlm.nih.gov/14578010/ - Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., … & Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of Psychopharmacology, 30(12), 1165-1180.
https://pubmed.ncbi.nlm.nih.gov/27909164/